
S177: EVALUATING SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER FOR MULTIPLE MYELOMA
Author(s) -
Akhlaghi T.,
Maclachlan K.,
Korde N.,
Mailankody S.,
Lesokhin A.,
Hassoun H.,
Lu S. X.,
Patel D.,
Shah U.,
Tan C.,
Derkach A.,
Lahoud O.,
Landau H. J.,
Shah G. L.,
Scordo M.,
Chung D. J.,
Giralt S. A.,
Usmani S. Z.,
Landgren O.,
Hultcrantz M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843600.33023.0e
Subject(s) - multiple myeloma , medicine , retrospective cohort study , biomarker , progression free survival , immunoglobulin light chain , cancer , log rank test , gastroenterology , single center , oncology , surgery , overall survival , immunology , antibody , chemistry , biochemistry